Use of methoxy polyethylene glycol-epoetin beta in stage 3, 4 or 5 non-dialysis chronic kidney disease
Utilización de eritropoyetina beta pegilada en enfermedad renal crónica en estadio 3, 4 o 5 no-D
Núria Padullés-Zamoraa, Dolors Comas-Sugrañesa, M. del Mar Pineda-Yustea, Ramon Jódar-Masanésa, Alberto Martínez-Castelaob
a Servicio de Farmacia, Hospital Universitari de Bellvitge, Institut d¿Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona,
b Servicio de Nefrología, Hospital Universitari de Bellvitge, Institut d¿Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona,
Read
12283
Timeswas read the article
3023
Total PDF
9260
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 58 | 81 | 139 |
| 2025 5 | 132 | 70 | 202 |
| 2025 4 | 95 | 28 | 123 |
| 2025 3 | 132 | 64 | 196 |
| 2025 2 | 104 | 44 | 148 |
| 2025 1 | 70 | 54 | 124 |
| 2024 12 | 55 | 27 | 82 |
| 2024 11 | 69 | 64 | 133 |
| 2024 10 | 53 | 42 | 95 |
| 2024 9 | 65 | 33 | 98 |
| 2024 8 | 52 | 58 | 110 |
| 2024 7 | 57 | 30 | 87 |
| 2024 6 | 72 | 42 | 114 |
| 2024 5 | 86 | 44 | 130 |
| 2024 4 | 70 | 37 | 107 |
| 2024 3 | 58 | 28 | 86 |
| 2024 2 | 61 | 43 | 104 |
| 2024 1 | 42 | 27 | 69 |
| 2023 12 | 69 | 36 | 105 |
| 2023 11 | 103 | 38 | 141 |
| 2023 10 | 99 | 44 | 143 |
| 2023 9 | 99 | 34 | 133 |
| 2023 8 | 96 | 21 | 117 |
| 2023 7 | 71 | 33 | 104 |
| 2023 6 | 74 | 24 | 98 |
| 2023 5 | 82 | 34 | 116 |
| 2023 4 | 82 | 25 | 107 |
| 2023 3 | 77 | 30 | 107 |
| 2023 2 | 38 | 27 | 65 |
| 2023 1 | 68 | 23 | 91 |
| 2022 12 | 73 | 35 | 108 |
| 2022 11 | 61 | 27 | 88 |
| 2022 10 | 47 | 31 | 78 |
| 2022 9 | 49 | 19 | 68 |
| 2022 8 | 58 | 49 | 107 |
| 2022 7 | 39 | 45 | 84 |
| 2022 6 | 56 | 32 | 88 |
| 2022 5 | 45 | 43 | 88 |
| 2022 4 | 51 | 51 | 102 |
| 2022 3 | 54 | 56 | 110 |
| 2022 2 | 55 | 52 | 107 |
| 2022 1 | 77 | 43 | 120 |
| 2021 12 | 57 | 50 | 107 |
| 2021 11 | 76 | 50 | 126 |
| 2021 10 | 74 | 49 | 123 |
| 2021 9 | 60 | 42 | 102 |
| 2021 8 | 84 | 45 | 129 |
| 2021 7 | 71 | 31 | 102 |
| 2021 6 | 60 | 25 | 85 |
| 2021 5 | 97 | 23 | 120 |
| 2021 4 | 145 | 97 | 242 |
| 2021 3 | 57 | 31 | 88 |
| 2021 2 | 125 | 23 | 148 |
| 2021 1 | 66 | 20 | 86 |
| 2020 12 | 58 | 18 | 76 |
| 2020 11 | 60 | 13 | 73 |
| 2020 10 | 30 | 21 | 51 |
| 2020 9 | 49 | 6 | 55 |
| 2020 8 | 40 | 14 | 54 |
| 2020 7 | 43 | 14 | 57 |
| 2020 6 | 74 | 11 | 85 |
| 2020 5 | 71 | 10 | 81 |
| 2020 4 | 39 | 21 | 60 |
| 2020 3 | 55 | 13 | 68 |
| 2020 2 | 67 | 18 | 85 |
| 2020 1 | 79 | 22 | 101 |
| 2019 12 | 55 | 26 | 81 |
| 2019 11 | 60 | 19 | 79 |
| 2019 10 | 39 | 12 | 51 |
| 2019 9 | 54 | 34 | 88 |
| 2019 8 | 41 | 14 | 55 |
| 2019 7 | 56 | 20 | 76 |
| 2019 6 | 54 | 15 | 69 |
| 2019 5 | 58 | 20 | 78 |
| 2019 4 | 103 | 34 | 137 |
| 2019 3 | 49 | 24 | 73 |
| 2019 2 | 32 | 18 | 50 |
| 2019 1 | 50 | 17 | 67 |
| 2018 12 | 103 | 39 | 142 |
| 2018 11 | 97 | 21 | 118 |
| 2018 10 | 112 | 20 | 132 |
| 2018 9 | 91 | 12 | 103 |
| 2018 8 | 71 | 19 | 90 |
| 2018 7 | 63 | 23 | 86 |
| 2018 6 | 55 | 11 | 66 |
| 2018 5 | 64 | 13 | 77 |
| 2018 4 | 82 | 12 | 94 |
| 2018 3 | 75 | 12 | 87 |
| 2018 2 | 64 | 7 | 71 |
| 2018 1 | 54 | 8 | 62 |
| 2017 12 | 68 | 9 | 77 |
| 2017 11 | 65 | 16 | 81 |
| 2017 10 | 46 | 10 | 56 |
| 2017 9 | 60 | 24 | 84 |
| 2017 8 | 38 | 33 | 71 |
| 2017 7 | 59 | 15 | 74 |
| 2017 6 | 54 | 12 | 66 |
| 2017 5 | 57 | 14 | 71 |
| 2017 4 | 45 | 10 | 55 |
| 2017 3 | 54 | 20 | 74 |
| 2017 2 | 45 | 14 | 59 |
| 2017 1 | 53 | 11 | 64 |
| 2016 12 | 58 | 8 | 66 |
| 2016 11 | 89 | 12 | 101 |
| 2016 10 | 157 | 11 | 168 |
| 2016 9 | 167 | 5 | 172 |
| 2016 8 | 197 | 5 | 202 |
| 2016 7 | 220 | 9 | 229 |
| 2016 6 | 141 | 0 | 141 |
| 2016 5 | 139 | 0 | 139 |
| 2016 4 | 135 | 0 | 135 |
| 2016 3 | 101 | 0 | 101 |
| 2016 2 | 143 | 0 | 143 |
| 2016 1 | 113 | 0 | 113 |
| 2015 12 | 134 | 0 | 134 |
| 2015 11 | 106 | 0 | 106 |
| 2015 10 | 120 | 0 | 120 |
| 2015 9 | 108 | 0 | 108 |
| 2015 8 | 94 | 0 | 94 |
| 2015 7 | 100 | 0 | 100 |
| 2015 6 | 51 | 0 | 51 |
| 2015 5 | 64 | 0 | 64 |
| 2015 4 | 6 | 0 | 6 |
Show all
